GlassScriptPhysician profile
Zainab Boxwala
NPI 1740934553
$987.54
in general payments reported to CMS, 2019-2025
16 companies · $988 in 2025
The $988 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.05 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $213.92 | 2025 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $185.21 | 2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $171.25 | 2025 | Uzedy |
| Janssen Pharmaceuticals, INC | $75.22 | 2025 | Invega Sustenna, Spravato |
| Neurocrine Biosciences, INC. | $54.99 | 2025 | |
| Abbvie INC. | $51.02 | 2025 | |
| Alkermes, INC. | $40.63 | 2025 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $29.81 | 2025 | Caplyta |
| Axsome Therapeutics, INC. | $27.55 | 2025 | Auvelity |
| Vanda Pharmaceuticals INC. | $24.72 | 2025 | Fanapt |
| Collegium Pharmaceutical, INC. | $22.83 | 2025 | Jornay Pm |
| Lundbeck LLC | $22.59 | 2025 | Rexulti |
| Almatica Pharma LLC | $19.88 | 2025 | Loreev Xr |
| Noven Therapeutics, LLC | $19.43 | 2025 | Secuado, Xelstrym |
| Biogen, INC. | $15.00 | 2025 | Zurzuvae |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $13.49 | 2025 | Relexxii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zainab Boxwala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.